logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HER2+ metastatic breast cancer: pyrotinib yields benefits in real-world analysis

Pyrotinib looks safe and effective as second-line or higher-line therapy.